A supply chain intelligence for Agilent Technologies, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Agilent Technologies, Inc. (A) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| SCLX | Scilex Holding Company | 72% | Reciprocal relationship from SCLX graph: ury strategy would be delayed, which could cause a material adverse effect on our business, prospects, and market price of our listed securities. If we are no… |
| TWST | Twist Bioscience Corporation | 72% | Reciprocal relationship from TWST graph: Reciprocal relationship from A graph: Reciprocal relationship from TWST graph: Reciprocal relationship from A graph: Reciprocal relationship from TWST graph: … |
| VOR | Vor Biopharma Inc. | 72% | Reciprocal relationship from VOR graph: lth authorities. Agreements with such manufacturers or suppliers may not be available to us at the time we would need to have that capability and capacity. Any… |
| WAT | Waters Corporation | 72% | Reciprocal relationship from WAT graph: . In addition, the Company continues to monitor environmental, health and safety regulations in countries in which it operates throughout the world, in particu… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-COMMERCE | USGOV-DEPARTMENT-OF-COMMERCE | 95% | USAspending awards from Department of Commerce: $288,417 across 3 awards. 1305M220PNCNS0377 PREVENTATIVE MAINTENANCE SERVICE FOR VARIOUS AGILENT SCIENTIFIC INSTRUMENTATION; 1333ND22PNB640181 5000 DEE… |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | 95% | USAspending awards from Department of Health and Human Services: $186,577 across 2 awards. 75N98026P00581 SURESCAN AGILENT TECHNOLOGIES INC:1109692 [26-005071]; 75N92E21P00188 MAINTENANCE AGREEMENT Q… |
| USGOV-DEPARTMENT-OF-HOMELAND-SECURITY | USGOV-DEPARTMENT-OF-HOMELAND-SECURITY | 90% | USAspending awards from Department of Homeland Security: $8,455 across 1 awards. HSCG4605PMMZF89 AUTO INJECTOR MODULE | Qwen corrected direction: Explicit government contract awards from DHS to Agile… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 90% | USAspending awards from Department of Veterans Affairs: $182,729 across 3 awards. 36C24624P0143 SPECIAL STAIN; 36C26322P0827 ANNUAL MAINTENANCE SERVICES FOR AGILENT SEAHORSE ANYALIZER TO SUPPORT THE … |
| USGOV-NATIONAL-AERONAUTICS-AND-SPACE-ADMINISTRAT | USGOV-NATIONAL-AERONAUTICS-AND-SPACE-ADMINISTRAT | 90% | USAspending awards from National Aeronautics and Space Administration: $10,132 across 1 awards. 80NSSC25PB065 REPAIR OF CARY 5000 SPECTROPHOTOMETER | Qwen corrected direction: Explicit government con… |
| KEYS | Keysight Technologies, Inc. | 72% | ary 31, 2026, service revenue increases reflected strong growth from contract repair and preventative maintenance services and compliance services. 33 Table of Contents Net Revenue By Segment Three M… |
| KEYS | Keysight Technologies, Inc. | 72% | Reciprocal relationship from KEYS graph: Reciprocal relationship from A graph: ary 31, 2026, service revenue increases reflected strong growth from contract repair and preventative maintenance servic… |
| TWST | Twist Bioscience Corporation | 72% | Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both larg… |
| VOR | Vor Biopharma Inc. | 72% | Reciprocal relationship from VOR graph: Reciprocal relationship from A graph: Reciprocal relationship from VOR graph: Reciprocal relationship from A graph: Reciprocal relationship from VOR graph: Rec… |
| WAT | Waters Corporation | 72% | Reciprocal relationship from WAT graph: rs continuously introduce new products and have instrument businesses that are generally more diversified than the Company’s business. Some competitors have gr… |
| VARIAN-MEDICAL-SYSTEMS-INC | VARIAN-MEDICAL-SYSTEMS-INC | 62% | fer from those taken by authorities in relevant jurisdictions, could potentially result in legal, reputational and operational risks. Furthermore, any actual or perceived failure to achieve our curre… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| A-DEBT | Debt stack $3.0B | 90% | Market cache reports total debt of $3.0B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| A-OWNER-DZ-BANK-AG-DEUTSCHE-ZENTRAL-GENOSSENSCHA | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 95% | 13F/ownership overlay lists DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main; shares held 17,502,013; value $2.42T; as of 2026-03-31. |
| A-OWNER-MASSACHUSETTS-FINANCIAL-SERVICES-CO-MA | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 95% | 13F/ownership overlay lists MASSACHUSETTS FINANCIAL SERVICES CO /MA/; shares held 12,624,090; value $1.47T; as of 2026-03-31. |
| A-OWNER-MORGAN-STANLEY | MORGAN STANLEY | 95% | 13F/ownership overlay lists MORGAN STANLEY; shares held 14,340,689; value $1.81T; as of 2026-03-31. |
| A-OWNER-BLACKROCK-INC | BlackRock, Inc. | 95% | 13F/ownership overlay lists BlackRock, Inc.; shares held 25,902,662; value $2.95T; as of 2026-03-31. |
| A-OWNER-STATE-STREET-CORP | STATE STREET CORP | 95% | 13F/ownership overlay lists STATE STREET CORP; shares held 12,764,632; value $1.46T; as of 2026-03-31. |
| A-OWNER-BARCLAYS-PLC | BARCLAYS PLC | 95% | 13F/ownership overlay lists BARCLAYS PLC; shares held 9,074,018; value $1.20T; as of 2026-03-31. |
| A-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | GEODE CAPITAL MANAGEMENT, LLC | 95% | 13F/ownership overlay lists GEODE CAPITAL MANAGEMENT, LLC; shares held 7,522,028; value $854.1B; as of 2026-03-31. |
| A-OWNER-VANGUARD-PORTFOLIO-MANAGEMENT-LLC | VANGUARD PORTFOLIO MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD PORTFOLIO MANAGEMENT LLC; shares held 14,352,682; value $1.64T; as of 2026-03-31. |
| A-OWNER-T-ROWE-PRICE-INVESTMENT-MANAGEMENT-INC | T. Rowe Price Investment Management, Inc. | 95% | 13F/ownership overlay lists T. Rowe Price Investment Management, Inc.; shares held 8,992,649; value $1.0B; as of 2026-03-31. |
| A-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC | VANGUARD CAPITAL MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD CAPITAL MANAGEMENT LLC; shares held 36,762,060; ownership 13.02%; value $4.19T; as of 2026-03-31. |
| A | Agilent Technologies, Inc. | 82% | George A. Scangos | CEO | gift |
| A | Agilent Technologies, Inc. | 82% | Pascal Soriot | CEO | unknown |
| A | Agilent Technologies, Inc. | 82% | Dow R. Wilson | CEO | unknown |
| A | Agilent Technologies, Inc. | 82% | Daniel K. Podolsky | Officer | n/a |
| A | Agilent Technologies, Inc. | 82% | Koh Boon Hwee | Officer | n/a |
| A | Agilent Technologies, Inc. | 82% | Mala Anand | Officer | N/A |
| A | Agilent Technologies, Inc. | 82% | Judy Gawlik Brown | Officer | N/A |
| A | Agilent Technologies, Inc. | 82% | Dolsten Mikael | Director | buy | 2158 shares |
| A | Agilent Technologies, Inc. | 82% | Koh Boon Hwee | Officer | N/A |
| A | Agilent Technologies, Inc. | 82% | Daniel K. Podolsky | Officer | N/A |
| A | Agilent Technologies, Inc. | 82% | Dow R. Wilson | CEO | unknown |
| A | Agilent Technologies, Inc. | 82% | Pascal Soriot | CEO | unknown |
| A | Agilent Technologies, Inc. | 82% | George A. Scangos | CEO | gift |
| A | Agilent Technologies, Inc. | 82% | Otis Brawley | Officer | unknown |
| A | Agilent Technologies, Inc. | 82% | Sue H. Rataj | Officer | N/A |
| A | Agilent Technologies, Inc. | 82% | Jonah Prevost Kirkwood | Officer | unknown |
| A | Agilent Technologies, Inc. | 82% | Angelica Riemann | Officer | n/a |
| A | Agilent Technologies, Inc. | 82% | Padraig McDonnell | Senior Vice President | unknown |
| A | Agilent Technologies, Inc. | 82% | Jonah Prevost Kirkwood | Officer | unknown |
| A | Agilent Technologies, Inc. | 82% | Padraig McDonnell | Senior Vice President | unknown |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | 100.00 | 2 | |
| BMYMP | Bristol-Myers Squibb Co | 100.00 | 2 | |
| VOR | Vor Biopharma Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| VIAV | Viavi Solutions Inc. | 100.00 | 2 | |
| TWST | Twist Bioscience Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| DVLT | Datavault AI Inc. | 100.00 | 2 | |
| ORMP | Oramed Pharmaceuticals Inc. | 100.00 | 2 | |
| SNYNF | Sanofi | 100.00 | 2 | |
| WAT | Waters Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| MCK | McKesson Corporation | 100.00 | 2 | |
| COLL | Collegium Pharmaceutical, Inc. | 100.00 | 2 | |
| BMY | Bristol-Myers Squibb Company | 100.00 | 2 | |
| JAZZ | Jazz Pharmaceuticals plc | 50.00 | 2 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 50.00 | 2 | |
| GM | General Motors Company | 50.00 | 2 | |
| BDX | Becton, Dickinson and Company | 50.00 | 2 | |
| GRFS | Grifols, S.A. | 50.00 | 2 | |
| AZTA | Azenta, Inc. | 50.00 | 2 | |
| ACET | Adicet Bio, Inc. | 50.00 | 2 | |
| CRL | Charles River Laboratories International, Inc. | 50.00 | 2 |